Pfizer nears Metsera takeover


Pfizer company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo

NEW YORK: Pfizer is closing in on a potential US$7.3bil takeover of weight-loss drug developer Metsera, the Financial Times has reported, citing unidentified sources.

The US pharma firm will acquire New York City-based Metsera for US$47.50 per share in cash, with an additional US$22.50 per share contingent on the achievement of certain performance milestones, the newspaper said

It added that the announcement could come soon, unless deal talks fall through.

Reuters could not immediately confirm the report.

Pfizer and Metsera did not immediately respond to a Reuters request for comment outside regular business hours.

Talks to acquire Metsera come just months after the biotech firm’s blockbuster Nasdaq debut.

This underscored surging investor appetite for companies developing next-generation weight-loss therapies.

The US$47.50-per-share bid marks a roughly 42.5% premium over Metsera’s latest closing price of US$33.32, which pegged its market value at about US$3.5bil, according to LSEG data.

The deal marks Pfizer’s latest bid to secure a foothold in the lucrative anti-obesity drug market, following setbacks in its own development efforts. — Reuters

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

MPOB: Malaysian palm oil industry well-positioned for EUDR compliance
Is Malaysia's AI boom at risk?
SC unveils Sukuk PRISMA
99 Speed Mart cautiously optimistic on resilient demand for essentials
CIMB Islamic targets doubling of Islamic wealth assets by 2030
Big Caring Group posts RM72.52mil net profit ahead of Bursa listing
Citaglobal completes Perak hydropower acquisitions, strengthening power generation in its new energy business
TWL Holdings proposes RM26mil acquisition of Wisma TWL
Dialog remains focused on long-term strategies amid global uncertainties
Yes Group IPO public portion subscribed 2.80 times ahead of ACE Market debut

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read